An international collaboration of researchers has identified several progressive series of mutations that occur in tumor cells responsible for aggressive subsets of neuroblastoma that relapse after chemotherapy.
Stephen Hunger, MD and a team of researchers used highly sensitive deep sequencing techniques to see how genetic changes in acute lymphoblastic leukemia cells evolve from diagnosis to remission and relapse.
